Moderna and Oxford receive UK authorization for Lynch syndrome cancer vaccine trial

June 8, 2026 7:01 PM

Moderna Inc. (NASDAQ: MRNA) and the University of Oxford received authorization from the UK's Medicines and Healthcare products Regulatory Agency ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found